PFIZER - Swing Trade Analysis with AI Signals

Last Updated Time : 05 Nov 25, 7:43 am

Swing Trade Rating: 3.5

📈 Positive

• 📘 Strong fundamentals: ROCE of 21.6% and ROE of 16.4% reflect healthy capital efficiency.
• 💰 EPS of ₹177 and P/E of 34.7 vs industry P/E of 33.1 suggest reasonable valuation.
• 💸 Dividend yield of 0.68% adds modest passive income.
• 📉 Debt-to-equity ratio of 0.01 indicates excellent financial discipline.
• 📈 FII holding increased by 0.20%, showing mild foreign investor interest.

⚠️ Limitation

• 📉 RSI at 40.2 and MACD at -1.08 signal weak momentum.
• 📉 Price hovering near DMA 200 (₹5,102) and below DMA 50 (₹5,243) suggests technical indecision.
• 📉 Volume (7,427) significantly below 1-week average (11,953) shows low liquidity.
• 📉 PEG ratio of 22.0 implies overvaluation relative to growth.
• 📉 Slight drop in PAT from ₹198 Cr. to ₹192 Cr. may dampen short-term sentiment.

🚫 Company Negative News

• 📉 No major negative news reported, but valuation and technical weakness are key concerns.

✅ Company Positive News

• 💊 PFIZER continues to benefit from its strong pharmaceutical pipeline and brand reputation.
• 📈 Stable earnings and low debt profile support long-term investor confidence.

🏦 Industry

• 🧬 Operates in the pharmaceutical sector, which is defensive and benefits from consistent demand.
• 📊 Industry P/E of 33.1 reflects moderate growth expectations and stable valuation.

🧾 Conclusion

• 📉 PFIZER is fundamentally strong but technically weak, making it a cautious swing trade candidate.
• 📍 Optimal entry: ₹5,050–₹5,100 (near DMA 200 and support zone).
• 🚪 Exit if held: ₹5,250–₹5,300 (near DMA 50) unless momentum improves.
• ⚠️ Suitable for swing trading with tight stop-loss and close monitoring of volume and trend signals.

I can also compare PFIZER’s swing setup with peers like GSK Pharma or Abbott India to refine your trade strategy.